Related references
Note: Only part of the references are listed.Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade
Alexandra Eichten et al.
CANCER RESEARCH (2016)
Vascular dysfunction in the pathogenesis of Alzheimer's disease - A review of endothelium-mediated mechanisms and ensuing vicious circles
Luigi Yuri Di Marco et al.
NEUROBIOLOGY OF DISEASE (2015)
ADAM12 and ADAM17 are essential molecules for hypoxia-induced impairment of neural vascular barrier function
Dan Cui et al.
SCIENTIFIC REPORTS (2015)
Regulated in Development and DNA Damage 1 Is Necessary for Hyperglycemia-induced Vascular Endothelial Growth Factor Expression in the Retina of Diabetic Rodents
Michael D. Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Diabetic retinopathy - ocular complications of diabetes mellitus
Martin M. Nentwich et al.
WORLD JOURNAL OF DIABETES (2015)
Characterization of Retinal Vascular and Neural Damage in a Novel Model of Diabetic Retinopathy
Lakshini Y. Weerasekera et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
A Ligand-Independent VEGFR2 Signaling Pathway Limits Angiogenic Responses in Diabetes
Carmen M. Warren et al.
SCIENCE SIGNALING (2014)
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
Alicia S. Chung et al.
NATURE MEDICINE (2013)
Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions
Ingeborg Klaassen et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2013)
Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood-Brain Barrier Damage in Early Ischemic Stroke Stage
Jie Liu et al.
JOURNAL OF NEUROSCIENCE (2012)
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Diana V. Do et al.
OPHTHALMOLOGY (2012)
The many faces of EMMPRIN-Roles in neuroinflammation
Smriti M. Agrawal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
INTRAVITREAL TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF REFRACTORY DIABETIC MACULAR EDEMA A Pilot Study From the Pan-American Collaborative Retina Study Group
Lihteh Wu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications
Elisabetta Dejana et al.
DEVELOPMENTAL CELL (2009)
Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial Cells
Svetlana M. Stamatovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Immunological mechanisms in the pathogenesis of diahetic retinopathy
Anthony P. Adamis et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown
Sukriti Nag et al.
ACTA NEUROPATHOLOGICA (2007)
Immunocytochemical and biochemical detection of EMMPRIN in the rat tooth germ: differentiation-dependent co-expression with MMPs and co-localization with caveolin-1 in membrane rafts of dental epithelial cells
W. Schwab et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2007)
Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells
Takashi Koto et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
The blood-brain barrier/neurovascular unit in health and disease
BT Hawkins et al.
PHARMACOLOGICAL REVIEWS (2005)
Links between CD147 function, glycosylation, and caveolin-1
W Tang et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Diabetic retinopathy and diabetic macular edema - Pathophysiology, screening, and novel therapies
TA Ciulla et al.
DIABETES CARE (2003)
Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice
T Nitta et al.
JOURNAL OF CELL BIOLOGY (2003)
Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice - Treatment with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice
W Schubert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characterization of low dose streptozotocin-induced progressive diabetes in mice
M Ito et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2001)
Share Paper
